WFA
AMED

Wipfli Financial Advisors’s Amedisys AMED Stock Holding History

Wipfli Financial Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$15K Buy
+151
New +$18K ﹤0.01% 1676

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wipfli Financial Advisors's AMED Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Amedisys (AMED) in Q3 2022: 151 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #1676 among its holdings.

286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Wipfli Financial Advisors held 151 shares of Amedisys worth $15K as of Q3 2022.
  • Amedisys was a new Wipfli Financial Advisors position in Q3 2022.
  • Amedisys made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1676 holding.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.